Health System Partner

Resources and insights tagged health system partner from Pedestal Health.

Publications

AbbVie Inc.University of Alabama Birmingham Ohio State University Harvard Medical School

Characterization of patient perception of odor severity in hidradenitis suppurativa using TARGET-DERM HS

University of Alabama Birmingham Wake Forest University

Healthcare Disparities in Hidradenitis Suppurativa in the US: TARGET-DERM HS

AbbVie Inc.University of Minnesota Mount Sinai

Correlation between achieving SALT 20 score and clinician- and patient-reported outcomes among patients diagnosed with alopecia areata in the US: An assessment from the TARGET-DERM AA registry

Northwestern University University of Minnesota Mount Sinai

Race and ethnicity sub-groups of alopecia areata patients have differing clinical characteristics: TARGET-DERM AA

AbbVie Inc.Mount Sinai

Generic vs. disease-specific patient reported outcome (PRO) instruments for assessing HRQoL burden among patients diagnosed with alopecia areata: Evidence from TARGET-DERM AA

140

Total Publications

Abstract/Manuscript

Oral Presentation

Poster Presentation

2026 · Poster Presentation · AbbVie Inc. · Dermatology

Characterization of patient perception of odor severity in hidradenitis suppurativa using TARGET-DERM HS

2026 · Poster Presentation · University of Alabama Birmingham · Dermatology

Healthcare Disparities in Hidradenitis Suppurativa in the US: TARGET-DERM HS

2025 · Poster Presentation · AbbVie Inc. · Dermatology

Correlation between achieving SALT 20 score and clinician- and patient-reported outcomes among patients diagnosed with alopecia areata in the US: An assessment from the TARGET-DERM AA registry

2025 · Poster Presentation · Northwestern University · Dermatology

Race and ethnicity sub-groups of alopecia areata patients have differing clinical characteristics: TARGET-DERM AA

2025 · Poster Presentation · AbbVie Inc. · Dermatology

Generic vs. disease-specific patient reported outcome (PRO) instruments for assessing HRQoL burden among patients diagnosed with alopecia areata: Evidence from TARGET-DERM AA

2025 · Abstract/Manuscript · UNC

The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET-NASH

2025 · Abstract/Manuscript · Kings College of London

Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction associated steatotic liver disease

2025 · Poster Presentation · University of Miami (FL) · Hepatology

Changes in The Fibrosis-4 (FIB-4) Score Accurately Reflects The Disease Trajectory of Metabolic Dysfunction Associated Steatotic Liver Disease

2025 · Poster Presentation · Saint Louis University · Hepatology

Clinical Characteristics of Patients With Presumed MASLD Who Meet Met-ALD Criteria in the TARGET-NASH Cohort

2025 · Poster Presentation · Madrigal · Hepatology

Relationship between non-invasive tests, clinical outcomes and liver biopsy among people with MASH under real-world conditions

2025 · Poster Presentation · German Diabetes Center (DDZ) / Heinrich Heine University Düsseldorf · Hepatology

Type 2 Diabetes and Obesity are The Main Metabolic Risk Factors for The Development of Cirrhosis in People with Metabolic Dysfunction Associated Steatohepatitis

2025 · Abstract/Manuscript · Northwestern University

Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry

2025 · Poster Presentation · Methods/Pharmacoepi

Missing the Mark: Treat-to-Target Gaps in Real-World Ulcerative Colitis Care

2025 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Leveraging public health infrastructures to support sexual health for women living in the Southern United States

2025 · Poster Presentation · Methods/Pharmacoepi

Treat-to-Target Gaps in Crohn’s Disease: Insights from Real-World Practice

2024 · Poster Presentation · German Diabetes Center (DDZ) / Heinrich Heine University Düsseldorf · Hepatology

Type 2 diabetes increases the risk of progression to metabolic dysfunction-associated steatohepatitis-related cirrhosis in a real world setting

2024 · Poster Presentation · University of Birmingham UK · Hepatology

Stability of the NASH-CHECK patient-reported outcome measure over time in patients with metabolic dysfunction-associated steatotic liver disease and stable clinical status

2024 · Poster Presentation · UNC · Hepatology

A prospective assessment of the impact of decompensation of cirrhosis on patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease

2024 · Poster Presentation · Merck · Hepatology

Time to Disease Progression and All-Cause Mortality in Adult MASH Patients in Real-World US Cohort

2024 · Poster Presentation · Merck · Hepatology

Characteristics of adult MASH patients and factors associated with MASH-relevant clinical endpoints in a real-world US cohort

2024 · Poster Presentation · UNC · Hepatology

Use of sodium-glucose transport protein 2 inhibitors and dipeptidyl peptidase 4 inhibitors in patients with MASLD in a real-world setting is associated with lower all-cause mortality

2024 · Poster Presentation · University of Birmingham UK · Hepatology

Real-World Use of Glucagon-Like Peptide 1 Receptor Agonists in Patients with MASLD: A Cross-Sectional Analysis from TARGET-NASH

2024 · Poster Presentation · Saint Louis University · Hepatology

A prospective assessment of disease progression impact on patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease

2024 · Poster Presentation · Madrigal · Hepatology

Non-invasive tests as a prediction tool to assess MASH resolution score

2024 · Poster Presentation · Madrigal · Hepatology

A longitudinal assessment of cardiovascular risk for NASH/MASH patients enrolled in TARGET-NASH

2024 · Poster Presentation · University of Miami (FL) · Hepatology

Complication-Free Survival in a Real-World Cohort of PBC Patients: Deep Versus Adequate ALP Response to UDCA

2024 · Poster Presentation · Medical University of South Carolina · Dermatology

Demographics and disease characteristics of patients with alopecia areata with comorbid atopic dermatitis, vitiligo or anxiety/depression: TARGET-DERM AA

2024 · Poster Presentation · George Washington University · Dermatology

Why Do Optimal Targets for Itch and Skin Clearance Matter in Atopic Dermatitis Treatment? Insights from the TARGET-DERM AD Registry

2024 · Poster Presentation · Novartis AG · Dermatology

Real-world study of hidradenitis suppurativa: skin lesions and pain are associated with Hurley Stage in TARGET-DERM HS

2024 · Poster Presentation · Wake Forest University School of Medicine · Gastroenterology

Predictors of Patients Receiving No Medication for Treatment of Eosinophilic Esophagitis in the United States: Data from the TARGET-EGIDS Cohort

2024 · Poster Presentation · Wake Forest University School of Medicine · Gastroenterology

Time to Diagnosis Among Patients with Eosinophilic Esophagitis in the United States

2024 · Abstract/Manuscript · Duke

Concordance of MASLD and NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort

2024 · Abstract/Manuscript · Heinrich Heine University Dusseldorf/German Diabetes Center

High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort

2024 · Poster Presentation · Heinrich Heine University Düsseldorf · Hepatology

Relationship between liver biopsy fibrosis stage and clinical outcomes among persons with MASLD/MASH

2024 · Oral Presentation · Saint Louis University · Hepatology

Use of glucagon-like peptide 1 receptor agonists in patients with MASLD in a real-world setting is associated with slower disease progression and lower all-cause mortality

2024 · Abstract/Manuscript · Northwestern University

Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry

2024 · Oral Presentation · Novartis AG · Dermatology

Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA

2024 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World Results From TARGET-IBD

2024 · Abstract/Manuscript · Harvard T.H. Chan School of Public Health

Use of tenofovir-based PrEP among pregnant women in South Africa

2024 · Abstract/Manuscript · University of Alabama at Birmingham

Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation Study

2024 · Poster Presentation · AbbVie Inc. · Dermatology

Persistent Inadequate Disease Control and Therapeutic Inertia in Moderate-to-Severe Atopic Dermatitis: A 12-month Longitudinal Analysis of Real-world Outcomes from the TARGET-DERM AD registry (Fall Clinical 2024)

2024 · Poster Presentation · AbbVie Inc. · Dermatology

Impact of Therapeutic Inertia on Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis: A 12-Month Longitudinal Study from the TARGET-DERM AD Registry (RAD Winter 2023)

2024 · Abstract/Manuscript

Use of Advanced Systemic Therapy in Patients with Moderate to Severe Atopic Dermatitis in the TARGET-DERM Registry

2023 · Poster Presentation · University of Birmingham / NIHR Birmingham BRC · Hepatology

NASH Progression Rates Based on Fibrosis and Inflammation (NAS): A Paired Biopsy Analysis From a Natural History Cohort in the US

2023 · Poster Presentation · Cleveland Clinic · Hepatology

A Prospective, Pragmatic Post-Authorisation Safety Study of Early Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients after Direct-Acting Antiviral (DAA) Therapy: DAA-PASS

2023 · Poster Presentation · AbbVie Inc. · Dermatology

Persistent Inadequate Disease Control and Therapeutic Inertia in Moderate-to-Severe Atopic Dermatitis: A 12-month Longitudinal Analysis of Real-world Outcomes from TARGET-DERM registry (RAD Winter 2023)

2023 · Poster Presentation · Dermatology

Impact of Therapeutic Inertia on Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis: A 12-Month Longitudinal Study from the TARGET-DERM AD Registry

2023 · Poster Presentation · Dermatology

The role of itch resolution and skin clearance in patient-reported atopic dermatitis severity and quality of life: Real-world Insights from TARGET-DERM AD

2023 · Abstract/Manuscript

Healthcare Disparities in Atopic Dermatitis: Insights from TARGET DERM Registry (2023 abstract)

2023 · Poster Presentation · University of Chicago · Gastroenterology

Outcomes of early vs. delayed advanced therapy among patients with moderate ulcerative colitis in the United States: TARGET-IBD

2023 · Poster Presentation · University of North Carolina at Chapel Hill · Gastroenterology

Treatment Journey among patients with moderate ulcerative colitis in the United States: TARGET-IBD

2023 · Oral Presentation · Methods/Pharmacoepi

Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-fracture Treatment Among Commercially Insured Postmenopausal Women in the United States

2023 · Poster Presentation · University of Birmingham (UK) · Methods/Pharmacoepi

Analysis of discrimination and calibration of two cardiovascular risk scores in patients with non-alcoholic steatohepatitis shows a need for improved accuracy of these models

2023 · Abstract/Manuscript · National University Hospital

Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort

2023 · Abstract/Manuscript · Mayo Clinic

Impact of itch on quality of life in people with primary biliary cholangitis: a plain language summary

2023 · Abstract/Manuscript · Northwestern University

Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort

2023 · Abstract/Manuscript · UCSD

Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Evaluation of a Natural Language Processing Model to Identify and Characterize Patients in the United States With High-Risk Non–Muscle-Invasive Bladder Cancer

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

When Emulating a Trial, Do as the Trialists Do: Missteps in Estimating Relative Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Booster Dose

2023 · Abstract/Manuscript · Harvard T.H. Chan School of Public Health

Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women

2023 · Abstract/Manuscript · Harvard T.H. Chan School of Public Health

High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study

2023 · Oral Presentation · Harvard T.H. Chan School of Public Health · Methods/Pharmacoepi

HIV risk perception and PrEP adherence among South African women planning for pregnancy and participating in STI screening

2023 · Poster Presentation · Dermatology

Healthcare Disparities in Atopic Dermatitis: Insights from TARGET DERM Registry (2023)

2022 · Poster Presentation · Saint Louis University · Hepatology

The Role of Disease Severity and Gender in Polypharmacy Among Patients with NAFLD Enrolled in TARGET-NASH

2022 · Poster Presentation · Novartis · Hepatology

Longitudinal ALT Trajectories are Generally Stable Among Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): An Investigation Using Artificial Recurrent Neural Networks

2022 · Poster Presentation · AbbVie Inc. · Dermatology

Epidemiology and Burden of Atopic Dermatitis Involving the Head, Neck, Face, and Hand: a Cross Sectional Study from the TARGET-DERM AD Cohort (RAD 2021)

2022 · Poster Presentation · Dermatology

Burden of Disease is Positively Associated with Disease Severity in Atopic Dermatitis

2022 · Poster Presentation · Dermatology

Use of Advanced Systemic Therapy in Patients with Moderate to Severe Atopic Dermatitis in the TARGET-DERM Registry (2022)

2022 · Poster Presentation · University of Chicago · Gastroenterology

The Impact of Early vs. Late Biologic Initiation Among Real World Patients with Crohn's Disease in TARGET IBD

2022 · Poster Presentation · University of Colorado Anschutz Medical Campus · Gastroenterology

Inflammation on Index Biopsy Predicts Loss of Remission Among Ulcerative Colitis Patients with Endoscopic Remission: a US Cohort Analysis

2022 · Abstract/Manuscript · Emory

Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease

2022 · Abstract/Manuscript · Mayo Clinic

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis

2022 · Abstract/Manuscript · Northwestern University

Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort

2022 · Abstract/Manuscript · Atrium Health

Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD

2022 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Postpartum Medicaid enrollment and churn in North Carolina

2022 · Oral Presentation · Botswana Ministry of Health and Wellness · Methods/Pharmacoepi

HIV Incidence in Botswana Rural Communities With High Antiretroviral Treatment Coverage: Results From the Botswana Combination Prevention Project, 2013-2017

2022 · Oral Presentation · Brigham and Women's Hospital · Methods/Pharmacoepi

Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention Project

2022 · Poster Presentation · Dermatology

Healthcare Disparities in Atopic Dermatitis: Insights from TARGET DERM Registry (2022)

2021 · Poster Presentation · AbbVie · Hepatology

Determination of Optimal Thresholds for Significant Fibrosis in NAFLD Using Non-Invasive Tests from TARGET-NASH Study

2021 · Poster Presentation · University of North Carolina at Chapel Hill · Gastroenterology

Histological Inflammation Predicts Loss of Remission Among Crohn's Patients with Endoscopic Remission: A US Cohort Analysis

2021 · Poster Presentation · University of North Carolina at Chapel Hill · Gastroenterology

Immunomodulators are Commonly Used as Concomitant Therapy with Vedolizumab or Ustekinumab: TARGET-IBD Real World Cohort

2021 · Poster Presentation · AbbVie Inc. · Gastroenterology

Biologic-naïve Patients with Crohn's Disease are More Likely to Achieve Mucosal Healing than Biologic-experienced Patients: TARGET-IBD Real World Cohort

2021 · Abstract/Manuscript · Heinrich Heine University Düsseldorf

Liver Biopsy in the Real World—Reporting, Expert Concordance and Correlation with a Pragmatic Clinical Diagnosis

2021 · Abstract/Manuscript · Heinrich Heine University Düsseldorf

Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study

2021 · Abstract/Manuscript · University of Michigan

Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH Study

2021 · Abstract/Manuscript · University of Michigan

Weight Loss and Weight Regain in Usual Clinical Practice: Results from the TARGET-NASH Observational Cohort

2021 · Abstract/Manuscript · Zucker School of Medicine at Hofstra

Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV

2021 · Abstract/Manuscript · Atrium Health

Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease

2021 · Abstract/Manuscript · University of Chicago

Methodology and initial results from a real-world observational cohort of patients with inflammatory bowel disease: TARGET-IBD

2021 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Medicaid Coverage Disruptions Among Children Enrolled in North Carolina Medicaid From 2016 to 2018

2021 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Factors Associated with Readmission in the US Following Hospitalization with COVID-19

2021 · Oral Presentation · University of Alabama at Birmingham · Methods/Pharmacoepi

Lipids testing trends before and after hospitalization for myocardial infarction among adults in the United States, 2008-2019

2021 · Poster Presentation · Dermatology

Epidemiology and Burden of Atopic Dermatitis Involving the Head, Neck, Face, and Hand: a Cross Sectional Study from the TARGET-DERM AD Cohort

2021 · Poster Presentation · Dermatology

Burden of Disease is Positively Associated with Disease Severity in Atopic Dermatitis (2021)

2020 · Poster Presentation · University of Miami (FL) · Hepatology

A Pragmatic Clinical Prognostic Classification Suitable for Universal Application Stratifies Patients with NAFLD by Risk of Mortality and Both Hepatic and Extrahepatic Outcomes

2020 · Poster Presentation · Heinrich-Heine University Düsseldorf · Hepatology

Heterogeneous Documentation and Poor Concordance of NASH Pathology May Limit its Clinical Utility in Real-World Practice

2020 · Poster Presentation · UNC · Hepatology

Fibrosis Assessed by Non-Invasive Tests is Similar to Liver Biopsy for Predicting Clinical Outcomes: A TARGET-NASH Study

2020 · Poster Presentation · Novartis · Hepatology

Predicting advanced fibrosis using non-invasive clinical tests and modern machine learning methods in TARGET-NASH

2020 · Poster Presentation · Hepatology

The Pervasive Impact of Pruritus on Quality of Life in Patients with Primary Biliary Cholangitis (PBC): Real World Experience in TARGET-PBC

2020 · Poster Presentation · Hepatology

Pruritus in Primary Biliary Cholangitis is Under-Treated in Clinical Practice: Results from TARGET-PBC

2020 · Poster Presentation · Atrium Health · Gastroenterology

Factors Associated with Biologic Discontinuation in Patients with Inflammatory Bowel Disease in TARGET-IBD

2020 · Abstract/Manuscript · University of Michigan

Opioid Use is More Common in Non-Alcoholic Fatty Liver Disease Patients with Cirrhosis, Higher Body Mass Index and Psychiatric Disease

2020 · Abstract/Manuscript · University of Michigan

Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Co-morbid Diseases

2020 · Abstract/Manuscript · University of Michigan

A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC

2020 · Abstract/Manuscript · University of Alabama at Birmingham

Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines

2020 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Patient Characteristics and Outcomes of 11,721 Patients with COVID19 Hospitalized Across the United States

2020 · Poster Presentation · Dermatology

International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale

2020 · Poster Presentation · Atrium Health · Gastroenterology

Oral Mesalamine Use in Crohn's Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study (ECCO)

2020 · Poster Presentation · Atrium Health · Gastroenterology

Medication Use and Comorbidities Among Elderly as Compared to Younger Patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort (ACG)

2019 · Poster Presentation · University of Michigan · Hepatology

Routinely Available Noninvasive Tests Perform Well in Identifying Patients with Advanced Fibrosis Due to NASH: Data from the TARGET-NASH Observational Cohort

2019 · Poster Presentation · Emory · Hepatology

Patient Reported Outcomes Among Pediatric Patients with Nonalcoholic Fatty Liver Disease: TARGET-NASH

2019 · Poster Presentation · Emory · Hepatology

Patterns of Medication Use Among Adult Patients with Elevated Serum ALT Levels in Patients with NAFLD: TARGET-NASH

2019 · Poster Presentation · University of Michigan · Hepatology

The Prescribing Patterns and Use of Statins in Patients with Nonalcoholic Fatty Liver Disease

2019 · Poster Presentation · University of Michigan · Hepatology

Opioid use in patients with NAFLD: prevalence and association with comorbidities and disease severity

2019 · Poster Presentation · University of Michigan · Hepatology

Lean NAFLD patients have lower prevalence of cardiovascular, metabolic and severe liver disease compared to overweight or obese patients with NAFLD

2019 · Poster Presentation · University of Miami (FL) · Hepatology

Primary biliary cholangitis (PBC)-autoimmune hepatitis (AIH) overlap syndrome: Characteristics and response to obeticholic acid (OCA) in TARGET-PBC, a diverse, large United States (US) real-world cohort (DDW 2019)

2019 · Poster Presentation · University of Miami (FL) · Hepatology

Change in Lipids: Characteristics and Response to Obeticholic Acid (OCA) in TARGET-PBC, a Diverse, Large United States (US) Real-world Cohort (DDW 2019)

2019 · Poster Presentation · Saint Louis University · Hepatology

Management of Hepatocellular Carcinoma (HCC) in a Real Life Multinational, Longitudinal, Observational Study (TARGET-HCC)

2019 · Poster Presentation · Saint Louis University · Hepatology

Regional, racial/ethnic, and socioeconomic disparities and treatment outcomes in patients with hepatocellular carcinoma (HCC) in the US

2019 · Poster Presentation · Zucker School of Medicine at Hofstra · Hepatology

Effectiveness of Tenofovir Alafenamide in Patients with Chronic Hepatitis B Treated in Usual Clinical Practice: Results from the TARGET-HBV Observational Cohort Study (AASLD)

2019 · Poster Presentation · Atrium Health · Gastroenterology

Oral Mesalamine Use in Crohn's Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study (ACG)

2019 · Poster Presentation · Gastroenterology

Medication Use and Comorbidities Among Elderly as Compared to Younger Patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort

2019 · Poster Presentation · University of Pennsylvania · Methods/Pharmacoepi

Factors Associated with Readmission Following COVID-19 Hospitalization

2019 · Oral Presentation · University of Alabama at Birmingham · Methods/Pharmacoepi

Lipid testing trends in the US before and after the release of the 2013 ACC/AHA cholesterol guidelines

2018 · Poster Presentation · Emory · Hepatology

Characterization of polypharmacy in patients with NAFLD

2018 · Poster Presentation · Columbia University Medical Center · Hepatology

Clinical Profile of Adults with Nonalcoholic Steatohepatitis (NASH) with and without Type 2 Diabetes Mellitus (T2DM)

2018 · Poster Presentation · University of Michigan · Hepatology

Nonalcoholic Fatty Liver Disease in Children in the U.S.: Clinical Characteristics of Participants Enrolled in TARGET-NASH

2018 · Poster Presentation · University of Michigan · Hepatology

Real World Evidence Showing High Rates of Cardiovascular Events in NAFLD Patients Regardless of Liver Disease (DDW)

2018 · Poster Presentation · University of Texas Southwestern · Hepatology

Patient-Reported Indicators of Health and Symptoms in US Patients with Primary Biliary Cholangitis (PBC)

2018 · Poster Presentation · Stanford · Hepatology

Primary Biliary Cholangitis (PBC) in the U.S.: Real World Effectiveness of Obeticholic Acid in TARGET-PBC (DDW)

2018 · Poster Presentation · Stanford · Hepatology

Primary Biliary Cholangitis (PBC) in the U.S.: Clinical Characteristics of Patients Enrolled in TARGET-PBC (DDW)

2018 · Poster Presentation · Atrium Health · Gastroenterology

Development of a Novel Longitudinal Observational Cohort of Adult and Pediatric Patients with Inflammatory Bowel Disease: TARGET-IBD

2018 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States

2018 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US

2017 · Poster Presentation · University of Michigan · Hepatology

Sustained Elevation in Alkaline Phosphatase is Associated with Greater Disease Severity in Real World NAFLD in TARGET-NASH

2017 · Poster Presentation · University of Michigan · Hepatology

Nonalcoholic Fatty Liver Disease in the U.S.: Clinical Characteristics of Patients Enrolled in TARGET-NASH (HEP DART)

2017 · Abstract/Manuscript · Emory

Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: the TARGET-NASH study

2017 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi